Impact of number of lines of therapy following docetaxel (D) in metastatic castration-resistant prostate cancer (mCRPC).

被引：1
|
作者：
Sonpavde, Guru
Bhor, Menaka
Hennessy, Daniel
Bhowmik, Debajyoti
Shen, Liji
Schnadig, Ian D.
机构：
[1] UAB Comprehens Canc Ctr, Birmingham, AL USA
[2] McKesson Specialty Hlth, The Woodlands, TX USA
[3] US Oncol Network, The Woodlands, TX USA
[4] Sanofi Aventis, Bridgewater, NJ USA
[5] Compass Oncol, Portland, OR USA
[6] US Oncol Network, Portland, OR USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.223
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
223
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer
    Armstrong, A. J.
    George, D. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (02) : 108 - 116
  • [42] ARN-509 in men with metastatic castration-resistant prostate cancer (mCRPC)
    Rathkopf, Dana E.
    Antonarakis, Emmanuel S.
    Shore, Neal D.
    Tutrone, Ronald
    Alumkal, Joshi J.
    Ryan, Charles J.
    Saleh, Mansoor N.
    Hauke, Ralph J.
    Maneval, Edna Chow
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [43] Combining molecular and functional imaging in metastatic castration-resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Scarpi, Emanuela
    Wetterskog, Daniel
    Caroli, Paola
    Romanel, Alessandro
    Lolli, Cristian
    Jayaram, Anuradha
    Gurioli, Giorgia
    Brighi, Nicole
    Poti, Giulia
    Wingate, Anna
    Schepisi, Giuseppe
    Matteucci, Federica
    Paganelli, Giovanni
    Demichelis, Francesca
    Attard, Gerhardt
    De Giorgi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [44] Modulation of plasma lipidomic signature in metastatic castration-resistant prostate cancer (mCRPC).
    Mak, Blossom
    Mahon, Kate Lynette
    Stockler, Martin R.
    Joshua, Anthony M.
    Zhang, Alison Yan
    Parnis, Francis
    Meikle, Peter
    Horvath, Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [45] Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer
    A J Armstrong
    D J George
    Prostate Cancer and Prostatic Diseases, 2010, 13 : 108 - 116
  • [46] Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer
    Madan, Ravi A.
    Karzai, Fatima H.
    Al Harthy, Munjid
    Petrylak, Daniel P.
    Kim, Joseph W.
    Arlen, Philip M.
    Rosner, Inger
    Theoret, Marc R.
    Cordes, Lisa
    Bilusic, Marijo
    Peer, Cody J.
    Dawson, Nancy A.
    Couvillon, Anna
    Hankin, Amy
    Williams, Moniquea
    Chun, Guin
    Owens, Helen
    Marte, Jennifer L.
    Lee, Min-Jung
    Tomita, Yusuke
    Yuno, Akira
    Trepel, Jane B.
    Lee, Sunmin
    Steinberg, Seth M.
    Gulley, James L.
    Figg, William D.
    Dahut, William L.
    BJU INTERNATIONAL, 2021, 127 (04) : 435 - 444
  • [47] Docetaxel in very elderly men with metastatic castration-resistant prostate cancer
    Wong, Hui-Li
    Lok, Sheau Wen
    Wong, Shirley
    Parente, Phillip
    Rosenthal, Mark
    PROSTATE INTERNATIONAL, 2015, 3 (02) : 42 - 46
  • [48] Pembrolizumab in men with heavily treated metastatic castration-resistant prostate cancer (mCRPC).
    Tucker, Matthew D.
    Zhu, Jason
    Berry, William R.
    Ramalingam, Sundhar
    Zhang, Tian
    Harrison, Michael Roger
    Wu, Yuan
    Healy, Patrick
    George, Daniel J.
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [49] Impact of docetaxel on quality of life (QoL) in elderly and non-elderly metastatic castration-resistant prostate cancer (mCRPC) patients (Pts)
    Rubio-Novella, S.
    Montes, A.
    Paredero Perez, I.
    Lozano Mejorada, R.
    Romero Laorden, N.
    Castro, E.
    Sanchez Hernandez, A.
    Olmos, D.
    Lorente Estelles, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S648 - S649
  • [50] Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC)
    Sonpavde, Guru
    Wang, Christopher G.
    Galsky, Matthew D.
    Oh, William K.
    Armstrong, Andrew J.
    BJU INTERNATIONAL, 2015, 116 (01) : 17 - 29
12345